Pfizer (PFE) Prices $31B Debt Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Pfizer Prices $31,000,000,000 Debt Offering
May 16, 2023 7:15 PM EDTNEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) (Pfizer) today announced the pricing of a debt offering consisting of eight tranches of notes (collectively, the Notes):
$3,000,000,000 aggregate principal amount of 4.650% Notes due 2025
$3,000,000,000 aggregate principal amount of 4.450% Notes due 2026
$4,000,000,000 aggregate principal amount of 4.450% Notes due 2028
$3,000,000,000 aggregate principal amount of 4.650% Notes due 2030
$5,000,000,000 aggregate principal amount of 4.750% Notes due 2033
$3,000,000,000 aggregate principal amount of 5.110% Notes due 2043
$6,000,000,000 aggregate principal amount of 5.300% Notes due 2053
$4,000,000,000 aggregate principal amount of 5.340% Notes due 2063
The Notes will be issued by Pfizers wholly-owned subsidiary, Pfizer Investment... More
